Globalization has focused attention on the relationship between intellectual property law and global public health. It has sparked debate over how to ensure the development of effective vaccines against HIV/AIDS, Avian flu, tuberculosis and similar epidemics, and to ensure timely access to preventive therapies. Can creative management of intellectual property result in better health outcomes? What are the “best practices” for fostering research and development? This program will focus on the new legal approaches to vaccine development. Our panel of experts will discuss innovations in intellectual property practice that are developing “on the ground.”

Featured Speakers
Labeeb Abboud, Esq.
General Counsel, International AIDS Vaccine Initiative

Usha R. Balakrishnan, M.B.A.
Founder and President, CARTHA

Professor Nan D. Hunter
Director, Brooklyn Law School Center for Health, Science and Public Policy

Josephine Johnston, LL.B., MBHL
Associate for Ethics, Law and Society, The Hastings Center

Kevin Outterson, J.D., LL.M.
Associate Professor of Law, West Virginia University College of Law

Brian Stanton, Ph.D.
Director, Division of Policy, Office of Technology Transfer, National Institutes of Health

Richard Wilder, Esq.
Partner, Sidley Austin LLP

Moderator
Mitchell Warren
Executive Director, AIDS Vaccine Advocacy Coalition

View video from the event (Windows Media).

Read more about the Center for Health, Science and Public Policy.